뎅기열 백신 시장 : 최종사용자별, 지역별

Dengue Vaccines Market is estimated to be valued at USD 434.8 Mn in 2026 and is expected to reach USD 1,689.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.3% from 2026 to 2033.

Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual's tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.

Key features of the study

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Dengue Vaccine based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

• By End User
  • Hospitals
  • Government Institutes
  • NGOs
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline
  • Merck & Co

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Developments
• Product Approval
• Regulatory Scenario

4. Global Dengue Vaccine Market, By End User 2026- 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Government Institutes
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• NGOs
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Dengue Vaccine Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2033
• North America
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Asia Pacific
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
• Middle East
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa
    • Rest of World
  • Market Size and Forecast, By End User, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)

6. Competitive Landscape

• Company Profiles
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

• References
• Research Methodology
• About us and Sales Contact